Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation

被引:48
|
作者
Shin, Dong Jin [1 ]
Trick, Alexander Y. [2 ]
Hsieh, Yu-Hsiang [3 ]
Thomas, David L. [4 ,5 ]
Wang, Tza-Huei [1 ,2 ,6 ]
机构
[1] Johns Hopkins Univ, Dept Mech Engn, Whiting Sch Engn, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Whiting Sch Engn, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Infect Dis Ctr Viral Hepatitis, Baltimore, MD USA
[6] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA
来源
SCIENTIFIC REPORTS | 2018年 / 8卷
关键词
VIRUS HCV RNA; PCR; AMPLIFICATION; MANIPULATION; INFECTION; DIAGNOSIS; ANTIBODY; RANGE;
D O I
10.1038/s41598-018-28124-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gold standard quantitative nucleic acid tests for diagnosis of viral diseases are currently limited to implementation in laboratories outside of the clinic. An instrument for conducting nucleic acid testing at the point-of-care (POC) that is easily operable by the clinician would reduce the required number of visits to the clinic and improve patient retention for proper treatment. Here we present a droplet magnetofluidic (DM) platform, which leverages functionalized magnetic particles to miniaturize and automate laboratory assays for use in the clinic at the POC. Our novel thermoformed disposable cartridge coupled to a portable multiaxial magnetofluidic instrument enables real-time PCR assays for quantitative and sensitive detection of nucleic acids from crude biosamples. Instead of laborious benchtop sample purification techniques followed by elution and spiking into PCR buffer, the user simply injects the biosample of interest into a cartridge with magnetic particles and loads the cartridge into the instrument. We demonstrate the utility of our platform with hepatitis C virus (HCV) RNA viral load quantitation from blood serum in approximately 1 hour. Clinical serum samples (n = 18) were directly processed on cartridges with no false positives and a limit of detection of 45 IU per 10 mu l sample injection.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia
    Thedja, Meta Dewi
    Wibowo, Dhita Prabasari
    El-Khobar, Korri Elvanita
    Ie, Susan Irawati
    Turyadi
    Setiawan, Lyana
    Murti, Ignatia Sinta
    Muljono, David Handojo
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (01): : 117 - 124
  • [22] A Portable Droplet Magnetofluidic Device for Point-of-Care Detection of Multidrug-Resistant Candida auris
    Lee, Pei-Wei
    Totten, Marissa
    Chen, Liben
    Chen, Fan-En
    Trick, Alexander Y.
    Shah, Kushagra
    Ngo, Hoan Thanh
    Jin, Mei
    Hsieh, Kuangwen
    Zhang, Sean X.
    Wang, Tza-Huei
    [J]. Frontiers in Bioengineering and Biotechnology, 2022, 10
  • [23] Point-of-care viral load testing and differentiated HIV care
    Dorward, Jienchi
    Drain, Paul K.
    Garrett, Nigel
    [J]. LANCET HIV, 2018, 5 (01): : E8 - E9
  • [24] Accelerating point-of-care HCV viral load testing
    Tang, Weiming
    Tao, Yusha
    Tucker, Joseph D.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (03): : 203 - 204
  • [25] An integrated paper-based sample-to-answer biosensor for nucleic acid testing at the point of care
    Choi, Jane Ru
    Hu, Jie
    Tang, Ruihua
    Gong, Yan
    Feng, Shangsheng
    Ren, Hui
    Wen, Ting
    Li, XiuJun
    Abas, Wan Abu Bakar Wan
    Pingguan-Murphy, Belinda
    Xu, Feng
    [J]. LAB ON A CHIP, 2016, 16 (03) : 611 - 621
  • [26] Validity of a point-of-care viral load test for hepatitis B in a low-income setting
    Woldemedihn, Gezahegn Mekonnen
    Rueegg, Corina Silvia
    Desalegn, Hailemichael
    Aberra, Hanna
    Berhe, Nega
    Johannessen, Asgeir
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2021, 289
  • [27] Picoliter droplet microfluidic immunosorbent platform for point-of-care diagnostics of tetanus
    Golberg, Alexander
    Yarmush, Martin L.
    Konry, Tania
    [J]. MICROCHIMICA ACTA, 2013, 180 (9-10) : 855 - 860
  • [28] Picoliter droplet microfluidic immunosorbent platform for point-of-care diagnostics of tetanus
    Alexander Golberg
    Martin L. Yarmush
    Tania Konry
    [J]. Microchimica Acta, 2013, 180 : 855 - 860
  • [29] The case for point-of-care HIV viral load testing in Africa
    Ferrand, Rashida A.
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (10): : 668 - 669
  • [30] Feasibility of a 30-Minute Sample-to-Answer Chlamydia Trachomatis, Neisseria Gonorrhea, and Trichomonas Vaginalis Multiplex Test on a Rapid Molecular Point-of-Care System*
    Nguyen, B.
    Pryce, M.
    Parker, E.
    Liang, J.
    Wei, C.
    Crowley, C.
    Green, A.
    Wu, B.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 230 (02) : S649 - S650